Skip to content

Clinical trials

Observational Schizophrenia Spectrum and Other Psychotic Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Spectrum and Other Psychotic Disorders Phase: Observational Country / region: United States Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beth Israel Deaconess Medical Center1
National Institute on Drug Abuse (NIDA)1
New York State Psychiatric Institute1
Northwell Health1
Stanford University1
University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia Spectrum and Other Psychotic Disorders6
Psychotic Disorders4
Mental Disorders2
Schizophrenia2
Anxiety Disorders1
Attention Deficit Disorder with Hyperactivity1
Bipolar Disorder1
Bipolar and Related Disorders1
Depressive Disorder1
Insulin Resistance1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.